- Home
- AGH vs GOVX Comparison
AGH vs GOVX Comparison
Compare AGH & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGH
- GOVX
- Stock Information
- Founded
- AGH 2014
- GOVX 2001
- Country
- AGH United States
- GOVX United States
- Employees
- AGH N/A
- GOVX N/A
- Industry
- AGH
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- AGH
- GOVX Health Care
- Exchange
- AGH NYSE
- GOVX Nasdaq
- Market Cap
- AGH 7.9M
- GOVX 7.6M
- IPO Year
- AGH 2025
- GOVX N/A
- Fundamental
- Price
- AGH $0.62
- GOVX $0.69
- Analyst Decision
- AGH
- GOVX Strong Buy
- Analyst Count
- AGH 0
- GOVX 5
- Target Price
- AGH N/A
- GOVX $12.40
- AVG Volume (30 Days)
- AGH 73.9K
- GOVX 3.3M
- Earning Date
- AGH 08-23-2025
- GOVX 08-05-2025
- Dividend Yield
- AGH N/A
- GOVX N/A
- EPS Growth
- AGH N/A
- GOVX N/A
- EPS
- AGH N/A
- GOVX N/A
- Revenue
- AGH $3,073,097.00
- GOVX $5,591,576.00
- Revenue This Year
- AGH N/A
- GOVX N/A
- Revenue Next Year
- AGH N/A
- GOVX N/A
- P/E Ratio
- AGH N/A
- GOVX N/A
- Revenue Growth
- AGH N/A
- GOVX N/A
- 52 Week Low
- AGH $0.52
- GOVX $0.43
- 52 Week High
- AGH $7.22
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- AGH N/A
- GOVX 42.50
- Support Level
- AGH N/A
- GOVX $0.60
- Resistance Level
- AGH N/A
- GOVX $0.77
- Average True Range (ATR)
- AGH 0.00
- GOVX 0.09
- MACD
- AGH 0.00
- GOVX -0.01
- Stochastic Oscillator
- AGH 0.00
- GOVX 47.27
About AGH AUREUS GREENWAY HOLDINGS INC
Aureus Greenway Holdings Inc own and operate two public golf country clubs in Florida. The golf country clubs include two golf-courses with over 13,000 yards of combined fairways, clubhouses boasting food and beverage options, aquatic golf ranges, and pro shops to assist any level of golfer and also host local golf leagues, golf-tournaments, and private events. Its golf country clubs is organized into four principal business segments: (i) golf recreation, retail golf products, and equipment and facilities rental, (ii) membership dues, (iii) food and beverage services. and (iv) ancillary services and amenities. All assets of the Company are located in Florida and all revenue is generated from Florida.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.